Arrowstreet Capital’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,087
Closed -$288K 1791
2024
Q4
$288K Buy
+10,087
New +$280K ﹤0.01% 1627
2020
Q3
Sell
-37,367
Closed -$716K 2313
2020
Q2
$716K Buy
+37,367
New +$792K ﹤0.01% 1874
2018
Q4
Sell
-5,900
Closed -$208K 1331
2018
Q3
$208K Buy
+5,900
New +$190K ﹤0.01% 1016
2016
Q4
Sell
-54,647
Closed -$960K 1628
2016
Q3
$960K Buy
54,647
+38,488
+238% +$582K ﹤0.01% 1080
2016
Q2
$191K Buy
+16,159
New +$191K ﹤0.01% 1279

Other funds holding AORT

Arrowstreet Capital's AORT Position: Q1 2025 in Review

Arrowstreet Capital sold out of Artivion (AORT) in Q1 2025, closing a stake of 10,087 shares — an estimated $288K sold.

Arrowstreet Capital first reported a position in AORT in Q2 2016 and held it in 5 quarters. The position peaked at $960K in Q3 2016. 184 funds tracked by Wall St. Rank hold AORT as of Q1 2025.

  • Arrowstreet Capital reported no remaining Artivion position as of Q1 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 10,087 Artivion shares in Q1 2025, an estimated $288K.
  • Arrowstreet Capital first reported a position in Artivion in Q2 2016 and held it in 5 quarters.
  • Arrowstreet Capital's Artivion position peaked at $960K in Q3 2016.
  • 184 funds tracked by Wall St. Rank held Artivion as of Q1 2025.

Based on Arrowstreet Capital's 13F filing for Q1 2025, filed 14 May 2025.